A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)

Clinical trial NCT04374253 · TERMINATED

Trial details

NCT number: NCT04374253
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2021-01-26
Primary completion: 2023-03-06
Enrollment: 1382

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.